France Confirms First Home-Grown Ebola Case as Doctor Flies In from DRC

PARIS — France has recorded its first-ever domestically confirmed case of Ebola, after a doctor who had been working in the Democratic Republic of Congo tested positive for the deadly haemorrhagic fever upon arriving in Paris, the health ministry announced on Wednesday.

The patient, a medic employed by the international humanitarian organisation ALIMA (The Alliance for International Medical Action), boarded a commercial flight from Kinshasa while still “almost asymptomatic – except for headaches”, according to officials. However, his condition “slightly deteriorated during the flight”, prompting immediate isolation and specialist care the moment he landed in the French capital – even before laboratory results officially confirmed the diagnosis.

This marks the first time the virus has been identified on French soil during the current outbreak, which has also spilled into neighbouring Uganda. It is also the first confirmed case of Ebola to be imported into Europe during this epidemic cycle. While France received two infected patients for treatment during the 2014 West African crisis, those individuals were diagnosed overseas before being transported.

Health authorities were quick to stress that the public risk remains minimal. The patient is now in a “stable condition” with a “very low” viral load, and contact-tracing efforts are already underway. Prime Minister Sébastien Lecornu is said to be monitoring the situation “very closely”, though the ministry reiterated that the likelihood of onward transmission within France is low.

The development comes as the DRC grapples with its 17th Ebola outbreak, declared on 15 May following a cluster of unexplained deaths in the conflict-ravaged Ituri province. Official figures now show more than 1,000 recorded cases and 267 fatalities – a mortality rate of roughly 25 per cent. However, public health experts widely believe the true scale is being underestimated, given the remoteness of the affected areas and ongoing insecurity.

Compounding the challenge, this outbreak is driven by the Bundibugyo strain of the virus, for which there is currently no licensed vaccine or specific treatment. Existing jabs, developed between 2018 and 2019, are effective only against the Zaire strain that fuelled previous major epidemics.

Just last month, an American surgeon who contracted Ebola in the DRC was airlifted to Berlin for emergency care. That patient, identified as Peter Stafford of the Serge charity, was discharged earlier this month after 17 days of treatment involving experimental therapies being trialled for this particular strain.

The European Centre for Disease Prevention and Control (ECDC) has maintained that the overall threat to European residents and travellers remains “very low”, a view echoed by the French health ministry. For now, all eyes are on the Paris isolation unit as authorities race to ensure this single imported case does not become a foothold for the virus on the continent.